Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perampanel long-term extension in refractory partial seizures
NCT00903786Phase 2Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Jun 2009
- Primary completion
- Aug 2016
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of perampanel in focal epilepsy, sponsored by Eisai Co., Ltd.. Started Jun 2009; status: completed.
02
Drugs
perampanel
03
Conditions
focal epilepsy
Beyond the preview
Go deeper on NCT00903786.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00903786.